Brain neurotransmitter changes in human narcolepsy

Neurology

Volumn 42, Issue 1, 1992, Pages 229-234

  Kish, S J ^a   Mamelak, M ^b   Slimovitch, C ^a   Dixon, L M ^a   Lewis, A ^c   Shannak, K ^a   DiStefano, L ^a   Chang, L J ^a   Hornykiewicz, O ^a,d  

^a Brain Research   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; ALPHA 1 ADRENERGIC RECEPTOR; DIHYDROXYPHENYLACETIC ACID; DOPAMINE; DOPAMINE 2 RECEPTOR; HOMOVANILLIC ACID; NORADRENALIN; PRAZOSIN; SEROTONIN; SEROTONIN RECEPTOR; SPIPERONE; TRITIUM;

ADULT; AGED; AUTOPSY; CASE REPORT; CAUDATE NUCLEUS; CONFERENCE PAPER; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; FEMALE; HUMAN; HUMAN TISSUE; MALE; NARCOLEPSY; NORADRENALIN BRAIN LEVEL; PRIORITY JOURNAL; PUTAMEN; SEROTONIN BRAIN LEVEL;

ADULT; AGED; BRAIN; CADAVER; CASE REPORT; DOPAMINE; FEMALE; HUMAN; HYDROXYINDOLEACETIC ACID; MALE; METHOXYHYDROXYPHENYLGLYCOL; MIDDLE AGE; NARCOLEPSY; NEUROTRANSMITTERS; SEROTONIN; SUPPORT, NON-U.S. GOV'T; TISSUE DISTRIBUTION;

EID: 0026499865     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.42.1.229     Document Type: Article

References (28)

1. Guilleminault C. Narcolepsy syndrome. In: Kryger MH, Roth T, Dement WC, eds. Principles and practice of sleep medicine. Philadelphia: WB Saunders, 1989:338-346.
2. Mefford IN, Baker TL, Boehme R, et al. Narcolepsy: biogenic amine deficits in an animal model. Science 1983;220:629-632.
3. Bowersox SS, Kilduff TS, Faull KF, Zeller-DeAmicis L, Dement WC, Ciaranello RD. Brain dopamine receptor levels elevated in canine narcolepsy. Brain Res 1987;402:44-48.
4. Miller JD, Faull KF, Bowersox SS, Dement WC. CNS monoamines and their metabolites in canine narcolepsy: a replication study. Brain Res 1990;509:169-171.
5. Mamelak M. A model for narcolepsy. Can J Psychol 1991;45:194-220.
6. Aldrich MS, Rogers AE. Exacerbation of human cataplexy by prazosin. Sleep 1989;12:254-256.
7. Broughton R, Mamelak M. The treatment of narcolepsy-cata- plexy with nocturnal gammahydroxybutyrate. Can J Neurol Sci 1979;6:1-6.
8. Mamelak M, Scharf M, Woods M. Treatment of narcolepsy with gammahydroxybutyrate: a review of clinical and sleep laboratory findings. Sleep 1986;9:285-289.
9. Mamelak M. Gammahydroxybutyrate: an endogenous regulator of energy metabolism. Neurosci Biobehav Rev 1989;13:187-198.
10. Steriade M, McCarley RW. Brainstem control of wakefulness and sleep. New York: Plenum Press, 1990.
11. Spokes EGS. An analysis of factors influencing measurements of dopamine, noradrenaline, glutamate decarboxylase and choline acetylase in human post-mortem brain tissue. Brain 1979;102:333-346.
12. Seeman P, Bzowej NH, Guan HC, et al. Human brain dopamine receptors in children and aging adults. Synapse 1987;1:399-404.
13. Riley H. An atlas of the basal ganglia, brain stem and spinal cord. New York: Hafner, 1960.
14. Olszewski J, Baxter D. Cytoarchitecture of the human brain stem. Philadelphia: Lippincott, 1954.
15. Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson’s disease. N Engl J Med 1988;318:876-880.
16. Felice LJ, Felice JD, Kissinger PT. Determination of catecholamines in rat brain parts by reverse-phase ion-pair liquid chromatography. J Neurochem 1978;31:1461-1465.
17. Seeman P, Ulpian C, Bergeron C, et al. Bimodal distribution of dopamine receptor densities in brains of schizophrenics. Science 1984;225:728-731.
18. Mignot E, Guilleminault C, Bowersox S, Rappaport A, Dement WC. Effect of aj-adrenoceptors blockade with prazosin in canine narcolepsy. Brain Res 1988;444:184-188.
19. Kramer RE, Dinner DS, Braun WE, Zachary AA, Teresi GA. HLA-DR2 and narcolepsy. Arch Neurol 1987;44:853-855.
20. Nakamura Y, Tokuno H, Moriizumi T, Kitao Y, Kudo M. Monosynaptic nigral inputs to the pedunculopontine tegmental nucleus neurons which send their axons to the medial reticular formation in the medulla oblongata: an electron microscopic study in the cat. Neurosci Lett 1989;103:145-150.
21. Dray A, Davies J, Oakley NR, Tongroach P, Vellucci S. The dorsal and medial raphe projections to the substantia nigra in the rat: electrophysiological, biochemical, and behavioural observations. Brain Res 1978;151:431-442.
22. Hilakivi I, Leppavuori A, Putkonen PTS. Prazosin increases paradoxical sleep. Eur J Pharmacol 1980;65:417-420.
23. Aghajanian GK, Bunney BS. Central dopaminergic neurons: neurophysiological identification and responses to drugs. In: Usdin E, Snyder SH, eds. Frontiers in catecholamine research. New York: Pergamon, 1973:643-648.
24. Beninato M, Spencer RF. The cholinergic innervation of the rat substantia nigra: a light and electron microscopic immunohistochemical study. Exp Brain Res 1988;72:178- 184.
25. Seeman P. Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1987;1:133-152.
26. Wong DF, Singer H, Pearlson G, et al. D2 dopamine receptors in Tourette’s syndrome and manic depressive illness [abstract!. J Nucl Med 1988;29:820.
27. Wong DF, Pearlson GD, Tune LE, et al. Update on PET methods for D2 dopamine receptors in schizophrenia and bipolar disorder. Schizophr Res 1989;2:115.
28. Wong DF, Young LT, Pearlson G, et al. D2 dopamine receptor densities measured by PET are elevated in several neuropsychiatric disorders. J Nucl Med 1989;30:731.